In mice intraperitoneally infected with the transgenic parasites, NY-ESO-1-specific CD4+ and CD8+ T cells were generated, triggering a range of MyD88- and IL-12-dependent tumor-specific humoral and cellular immune responses. This evidence concerns the gene CD4 and neoplasm.